The present study demonstrates for the first time that activation of the A2A-R signaling pathway can modulate the fibrosis, hypertrophy and subsequent left ventricular dysfunction that follow TAC using a murine model in which over-expression of the A2A receptor can be controlled and is cardiac specific. The gene discussed is ADORA2A; the disease is persistent truncus arteriosus.